Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 24 09:34AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-3.79 Insider Own34.94% Shs Outstand47.69M Perf Week66.67%
Market Cap98.30M Forward P/E- EPS next Y-0.46 Insider Trans0.00% Shs Float31.20M Perf Month25.77%
Income-58.20M PEG- EPS next Q-0.24 Inst Own18.43% Short Float1.90% Perf Quarter10.81%
Sales48.78M P/S2.02 EPS this Y80.95% Inst Trans-8.34% Short Ratio0.28 Perf Half Y-38.99%
Book/sh-1.38 P/B- EPS next Y-4.55% ROA-72.92% Short Interest0.59M Perf Year-80.75%
Cash/sh0.62 P/C3.31 EPS next 5Y- ROE-1715.20% 52W Range1.04 - 10.94 Perf YTD-45.19%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-81.26% Beta-0.06
Dividend TTM- Quick Ratio0.72 Sales past 5Y-5.58% Gross Margin75.38% 52W Low97.10% ATR (14)0.37
Dividend Ex-Date- Current Ratio0.81 EPS Y/Y TTM-1413.99% Oper. Margin-156.77% RSI (14)57.39 Volatility57.95% 22.69%
Employees252 Debt/Eq- Sales Y/Y TTM- Profit Margin-119.31% Recom1.00 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q126.30% Payout- Rel Volume1.17 Prev Close2.28
Sales Surprise2.02% EPS Surprise139.29% Sales Q/Q- EarningsMay 14 BMO Avg Volume2.09M Price2.05
SMA2036.99% SMA5012.89% SMA200-35.13% Trades Volume146,567 Change-10.09%
Date Action Analyst Rating Change Price Target Change
Feb-09-24Initiated Jefferies Buy $5
Jun-20-24 03:49PM
Jun-14-24 01:44PM
Jun-11-24 10:50AM
08:00AM Loading…
Jun-05-24 08:00AM
May-30-24 08:00AM
May-29-24 04:05PM
May-15-24 08:00AM
May-14-24 12:53PM
May-02-24 08:00AM
Apr-30-24 08:30AM
Apr-17-24 08:31AM
08:00AM Loading…
Apr-04-24 08:00AM
Mar-21-24 12:53PM
Mar-13-24 08:30AM
Mar-12-24 08:00AM
Mar-04-24 08:30AM
Feb-20-24 04:05PM
Feb-08-24 08:30AM
Jan-29-24 08:00AM
Jan-23-24 09:04AM
Jan-17-24 08:00AM
Jan-11-24 08:00AM
Jan-08-24 08:00AM
Jan-05-24 08:00AM
08:00AM Loading…
Jan-02-24 08:00AM
Nov-13-23 08:00AM
Nov-06-23 04:05PM
Oct-11-23 08:00AM
Oct-04-23 08:00AM
Sep-18-23 08:00AM
Aug-29-23 08:00AM
Aug-28-23 08:00AM
Aug-04-23 01:33PM
Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chardon BenoitChief Commercial OfficerDec 12 '23Option Exercise1.19165,539197,562199,183Dec 14 07:17 PM